G9S), a
mining company focused on developing high-quality and low-risk mineral
resource and energy prospects, today announced that the Company and Mayan
Gold, Inc have successfully closed their milestone Strategic Cross
Investment and Gold Field Development Agreement.
Succeeding an extensive due diligence period following the initial
agreement in principle as announced on January 28, 2008, both companies
have executed the final agreement providing for the exchange of G&S
Minerals common stock and warrants for a 100% interest in the El Transito
concession. All related documents and obligations have been mutually signed
and completed, and the transaction is now deemed closed.
The Company will provide further information as to the specific terms and
details of the executed agreement in a subsequent announcement. G&S
management and the Company Board of Directors are pleased to have completed
this important agreement with Mayan Gold, Inc, and continue to seek and
develop mineral and energy prospects to maximize shareholder value.
ABOUT G & S MINERALS, INC.:
G & S Minerals, Inc. (which also does business under the name "Gold &
Silver Minerals") is a mining company focused on acquiring and developing
high-quality, low-risk mineral resource and energy prospects. G & S
Minerals is aggressively pursuing opportunities to develop working
interests in mineral properties that offer a short time to production, as
well as significant upside exploration potential. In addition, G & S
Minerals is investigating opportunities for corporate transactions that
will expand the mineral and resource portfolio. By leveraging its network
of industry contacts, management expertise, and its targeted acquisitions,
G & S Minerals is working to build rapid asset growth, near-term cash flow,
and shareholder value. Additional information is available at G & S
Minerals' website at www.gold-silverco.com.
Forward-Looking Statements:
This press release contains forward-looking statements within the meaning
of applicable securities laws, including statements about the Company's
stock quotation and disclosure plans and actions, as well as the
anticipated actions of third parties. These statements are subject to
numerous assumptions and uncertainties, many of which are outside the
Company's control. Statements in this document are based on information
the Company believes to be reasonable, but involve significant
uncertainties as to the timing and outcome of the Company's submissions and
the review process at Pink OTC Markets Inc. Such uncertainties include the
substance and timing of the review process, any resulting comments or
questions, intervening changes in the Company's status and business, and
the Company's ability to obtain and provide necessary current information
to Pink OTC Markets Inc. Actual results and timetables could vary
significantly from the estimates presented. Readers are cautioned not to
put undue reliance on forward-looking statements. Except as noted above,
the Company disclaims any obligation to update such forward-looking
statements, whether as a result of new information, future events, or
otherwise.